🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: K-877

Found 23 matching trials

A Phase III Confirmatory Study of K-877 (Pemafibrate) in Patients With Hypercholesterolemia and Statin Intolerance

PHASE3

To investigate the efficacy and safety of K-877 Extended Release 0.2 mg/day...

Status

Completed

Location

Nakayama Clinic

Start Date

2023-05-01

Trial ID

NCT05923281

Treatments Being Tested

K-877 0.2 mg/day (once daily)K-877 0.4 mg/day (once daily)Placebo (once daily)

Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function

PHASE3

The purpose of this study is to evaluate the efficacy and safety of K-877 i...

Status

Completed

Location

Central Research Associates, Inc.

Start Date

2016-11-28

Trial ID

NCT03001817

Treatments Being Tested

K-877 Fenofibrate Placebo (for K-877)Placebo (for Fenofibrate)

Drug-Drug Interaction Study in Health Adult Volunteers

PHASE1

The purpose of this study is to assess the effects of K-877 on the pharmaco...

Status

Completed

Location

PPD

Start Date

2014-08

Trial ID

NCT02273986

Treatments Being Tested

Digoxin K-877

Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR

PHASE2

A study to evaluate the efficacy of K-877 extended release (ER) once daily ...

Status

Completed

Location

Pinnacle Research Group

Start Date

2020-06-10

Trial ID

NCT04447820

Treatments Being Tested

K-877-ER (Dose A)K-877-ER (Dose B)K-877-IR

Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)

PHASE3

The primary objective of the study is to determine whether pemafibrate admi...

Status

Terminated

Location

Synexus Clinical Research US, Inc.

Start Date

2017-03-23

Trial ID

NCT03071692

Treatments Being Tested

K-877 Placebo

Drug-Drug Interaction Study in Healthy Adult Volunteers

PHASE1

The purpose of this study is to assess the effects of rifampin on the pharm...

Status

Completed

Location

PPD

Start Date

2014-09

Trial ID

NCT02275962

Treatments Being Tested

K-877 Rifampin

Drug-Drug Interaction Study in Healthy Adult Volunteers

PHASE1

The primary objective of this study is to assess the effects of cyclosporin...

Status

Completed

Location

PPD

Start Date

2014-06

Trial ID

NCT02276001

Treatments Being Tested

K-877 Cyclosporine

Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment

PHASE3

The purpose of this study is to evaluate the efficacy and safety of K-877 i...

Status

Completed

Location

Central Research Associates, Inc.

Start Date

2016-11-26

Trial ID

NCT03011450

Treatments Being Tested

K-877 Fenofibrate Placebo (for K-877)

A Thorough Corrected QT Interval Trial

PHASE1

The purpose of this study is to determine the effects of K-877 on ECG param...

Status

Completed

Location

Multiple Locations

Start Date

2014-01

Trial ID

NCT02073084

Treatments Being Tested

K-877 Low Dose Moxifloxacin Placebo K-877 High Dose

Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452

PHASE1

The goal of this clinical trial is to demonstrate the bioequivalence of sin...

Status

Completed

Location

PPD - Austin Research Unit

Start Date

2023-02-24

Trial ID

NCT05722262

Treatments Being Tested

K-001 K-877-ER CSG452

Previous Next